Association of osteoporosis and bone medication with the periodontal condition in elderly women

[31] Weyant RJ(2013)Risk factors for periodontal disease Periodontol 2000 62 59-786

[32] Pearlstein ME(2000)Associations of periodontal disease with femoral bone mineral density and estrogen replacement therapy: cross-sectional evaluation of us adults from NHANES III J Clin Periodontol 27 778-394

[33] Churak AP(2001)Gingival recession-its significance and management J Dent England 29 381-170

[34] Forrest K(2011)Is long-term bisphosphonate therapy associated with benefits to the periodontium in postmenopausal women? Menopause 18 164-23

[35] Famili P(2015)Diagnosis and management of osteonecrosis of the jaw: a systematic review and international consensus J Bone Miner Res 30 3-313

[36] Cauley JA(2013)Vitamin d supplementation in elderly or postmenopausal women: a 2013 update of the 2008 recommendations from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) Curr Med Res Opin 29 305-1256

[37] Famili P(2013)Plasma 25-hydroxyvitamin d concentrations and periodontal disease in postmenopausal women J Periodontol 84 1243-773

[38] Cauley J(1998)A unitary model for involutional osteoporosis: estrogen deficiency causes both type I and type II osteoporosis in postmenopausal women and contributes to bone loss in aging men J Bone Miner Res 13 763-451

[39] Suzuki JB(2011)The unitary model for estrogen deficiency and the pathogenesis of osteoporosis: is a revision needed? J Bone Miner Res 26 441-1736

[40] Weyant R(2010)Intracortical remodelling and porosity in the distal radius and post-mortem femurs of women: a cross-sectional study Lancet 375 1729-402

[31] Weyant RJ(2013)Risk factors for periodontal disease Periodontol 2000 62 59-786

[32] Pearlstein ME(2000)Associations of periodontal disease with femoral bone mineral density and estrogen replacement therapy: cross-sectional evaluation of us adults from NHANES III J Clin Periodontol 27 778-394

[33] Churak AP(2001)Gingival recession-its significance and management J Dent England 29 381-170

[34] Forrest K(2011)Is long-term bisphosphonate therapy associated with benefits to the periodontium in postmenopausal women? Menopause 18 164-23

[35] Famili P(2015)Diagnosis and management of osteonecrosis of the jaw: a systematic review and international consensus J Bone Miner Res 30 3-313

[36] Cauley JA(2013)Vitamin d supplementation in elderly or postmenopausal women: a 2013 update of the 2008 recommendations from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) Curr Med Res Opin 29 305-1256

[37] Famili P(2013)Plasma 25-hydroxyvitamin d concentrations and periodontal disease in postmenopausal women J Periodontol 84 1243-773

[38] Cauley J(1998)A unitary model for involutional osteoporosis: estrogen deficiency causes both type I and type II osteoporosis in postmenopausal women and contributes to bone loss in aging men J Bone Miner Res 13 763-451

[39] Suzuki JB(2011)The unitary model for estrogen deficiency and the pathogenesis of osteoporosis: is a revision needed? J Bone Miner Res 26 441-1736

[40] Weyant R(2010)Intracortical remodelling and porosity in the distal radius and post-mortem femurs of women: a cross-sectional study Lancet 375 1729-402